Resources

ISCT Poster - Synecta Hero CAR-T

September 2026

MARS GoFast™ Rapid Manufacturing with Synecta™ T1 Activation Shows Higher Observed Frequency of Multifunctional “Hero” CAR-T Cells

Interview with Jim Riley

August 2026

Jim Riley PhD discusses his next clinical trial in HIV & B-cell hematological malignancies

Webinar

May 2026

Cell-derived Nanoparticles: A New Paradigm for CAR-T Cell Activation and Manufacturing; Presentations by UCSF & Ori Biotech

ISCT Poster - Synecta with IRO® Platform

May 2026

Synecta enhances lentiviral transduction and manufacturing efficiency in closed, automated cell therapy platform

AACR Poster - Synecta for iNKT Cells

April 2026

Generation of scalable off-the-shelf iNKT therapies with Synecta T1

AACR Poster - Synecta with Electroporation

April 2026

Synecta T1 and Flowfect® Enhance Non-Viral Engineering Efficiency and Manufacturing Scalability of CD19-Directed CAR-T Cells For Hematologic Malignancies